3545 results for «2124»
3545 results
Redefining and optimising LAA closure: LIVE Educational Case from University Hospitals Harrington Heart & Vascular Institute - Cleveland (Ohio), USA
11 Sep 2025 – From PCR Rio Valves 2025
Experience a LIVE educational case from University Hospitals Harrington Heart & Vascular Institute demonstrating a minimalist approach to left atrial appendage (LAA) closure. Learn about the use of intracardiac echocardiography, conscious sedation, and local anaesthesia to improve safety and efficiency, along with patient selection, imaging integration,...
Precision in mitral TEER
11 Sep 2025 – From PCR Rio Valves 2025
Join this live educational session from Bordeaux University Hospital to gain expert insights into mitral transcatheter edge-to-edge repair (TEER). Explore optimal timing and clinical decision-making for mitral regurgitation treatment, and discover how the PASCAL Precision system enhances procedural precision across diverse mitral anatomies. Witness real-time strategies,...
Tailored transfemoral TAVI in complex anatomies - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Join this live educational session from Hospital Copa D'Or in Rio de Janeiro, Brazil, focusing on tailored transfemoral TAVI in patients with complex anatomies. Gain critical insights into pre-procedural planning, decision-making strategies for high-risk cases, and technical nuances that optimize procedural success, all demonstrated through expert...
TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review
09 Nov 2021
The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
